The Nutshell

» cancer and policy

Daily News Roundup

Most Recent

image: US Voters Oppose Science Cuts

US Voters Oppose Science Cuts

By | September 24, 2012

Many Americans who are likely to vote in upcoming elections are not in favor of across-the-board cuts to non-discretionary funding.

3 Comments

image: Lab Animals Lose Transportation

Lab Animals Lose Transportation

By | September 24, 2012

FedEx and UPS make further restrictions on their shipments of animals for experimental use.

20 Comments

image: GM Crop Concerns

GM Crop Concerns

By | September 20, 2012

A questionable study claims that rats fed approved genetically modified maize developed cancer and died early.

13 Comments

image: University Library Ditches ACS

University Library Ditches ACS

By | September 18, 2012

In protest against high-priced journal packages, the library at SUNY Potsdam will end its subscription to American Chemical Society online journal package.

0 Comments

image: Dotting “i”s and Crossing “t”s

Dotting “i”s and Crossing “t”s

By | September 17, 2012

As federal budgets tighten, the US government is getting serious about enforcing reporting and administrative rules that accompany academic grants.

2 Comments

image: Cantley Changes Jobs

Cantley Changes Jobs

By | September 14, 2012

Renowned cancer researcher Lewis Cantley is leaving Harvard to lead a new cancer center at Weill Cornell Medical College and NewYork-Presbyterian Hospital.

0 Comments

image: Calif RAs to Get Union Rights?

Calif RAs to Get Union Rights?

By | August 27, 2012

The California legislature takes steps to broaden the ability of graduate students to unionize by extending collective bargaining rights to research assistants.

0 Comments

image: Paul Ryan's Science Report

Paul Ryan's Science Report

By | August 20, 2012

The presumed vice-presidential candidate gets a mixed review on science funding and attitudes.

8 Comments

image: Court Rules Gene Patents Valid

Court Rules Gene Patents Valid

By | August 17, 2012

Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.

8 Comments

image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Cannibalism: Not That Weird
    Reading Frames Cannibalism: Not That Weird

    Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

  4. Can Plants Learn to Associate Stimuli with Reward?
Business Birmingham